Vktx stock price momentum indicators remain constructive

Momentum indicators remain constructive. Novo Nordisk A/S (NVO) : Free Stock Analysis Report Beyond fundamentals, Viking is widely viewed as a buyout target given the projected $50–100 billion GLP market by 2030, with even a third entrant poised to capture meaningful share. The ability of VK2735 to enable rapid initial weight loss with high doses and transition patients to oral maintenance regimens without injections makes it uniquely compelling. Taken together, VKTX offers asymmetric upside, with catalysts ranging from clinical milestones to M&A, and potential 5x returns over the next year. vktx stock price currently consolidates after a recent upward spike, hovering around $